Literature DB >> 10932295

Remission of HIV myelopathy after highly active antiretroviral therapy.

A Di Rocco, M Tagliati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10932295     DOI： 10.1212/wnl.55.3.456

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  Pilot study of intravenous immunoglobulin in HIV-associated myelopathy.

Authors:  Katia Cikurel; Lauren Schiff; David M Simpson
Journal:  AIDS Patient Care STDS       Date:  2009-02       Impact factor: 5.078

Review 2.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

3.  Atypical HIV-vacuolar myelopathy: a case report.

Authors:  Tau Mongezi; Joseph Sibi; George Jerry; Ibañez-Valdés Lourdes de Fátima; Dubula Tozama; Foyaca Sibat Humberto
Journal:  Eur J Med Res       Date:  2021-02-01       Impact factor: 2.175

4.  Successful Treatment of Human Immunodeficiency Virus-Associated Highly Active Antiretroviral Therapy-Resistant Vacuolar Myelopathy with Intravenous Immunoglobulin.

Authors:  Lidiia N Prakhova; Aleksandr G Ilves; Svetlana N Kizhlo; Zhanna I Savintseva
Journal:  Ann Indian Acad Neurol       Date:  2020-02-25       Impact factor: 1.383
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.